Increased NPC1L1 and serum cholesterol in a chronic rejection rat

被引:1
|
作者
Zhu, Yanfei [1 ]
Zhou, Jing [2 ]
机构
[1] Nanjing Med Univ, Wuxi Peoples Hosp, Dept Gen Surg, Wuxi 214023, Jiangsu Provinc, Peoples R China
[2] Nanjing Med Univ, Wuxi Peoples Hosp, Dept Pathol, Wuxi 214023, Jiangsu Provinc, Peoples R China
来源
CLINICAL AND INVESTIGATIVE MEDICINE | 2011年 / 34卷 / 03期
基金
中国国家自然科学基金;
关键词
CARDIAC TRANSPLANT RECIPIENTS; SMALL-INTESTINE TRANSPLANTATION; ENDOTHELIAL DYSFUNCTION; HYPERCHOLESTEROLEMIA; EZETIMIBE; HYPERLIPIDEMIA; ABSORPTION; ATHEROSCLEROSIS; THERAPY; PROTEIN;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Purpose: To measure serum cholesterol and triglyceride levels and NPC1L1 mRNA and protein as an index of cholesterol absorption during the development of chronic rejection (CR) in a rat model of intestinal transplantation. Methods: Rats were randomly divided into two groups: Group 1 (n=20) underwent syngenic Lewis-to-Lewis transplantation and Group 2 (n=20) underwent allogenic F344-to-Lewis transplantation as well as treatment with FK506. Blood samples and intestinal tissue were procured on the 190th day after operation. Histological changes were analyzed and the semiquantitative scores of histological parameters were compared. The serum levels of cholesterol and triglyceride were determined. The expression of Niemann-Pick C1 Like 1(NPC1L1) mRNA and protein were analyzed by Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) and immunohistochemistry, respectively. Results: All the animals survived for the 190 days. The appearance and histology of isografts were almost normal whereas the allografts displayed thickened bowel wall and mesenteric fibrosis, concentric intimal thickening and interstitial fibrosis and inflammatory in filtration. The histology scores displayed a significant difference between the allografts and isografts (P<0.001). No differences were observed for triglycerides for the two groups. The serum cholesterol levels increased significantly in the allogenic group in comparison with the syngenic group (P=0.034), while no difference was observed for triglyceride levels between groups. RT-PCR showed that the expression of NPC1L1 of allografts increased significantly (P=0.004). Immunohistochemistry confirmed RT-PCR findings. Conclusions: Neointima formation and mesenteric fibrosis were the dominant pathological features. The increased expression of NPC1L1 might contribute to hypercholesterolemia, which may be involved in the pathogenesis of transplant arteriosclerosis.
引用
收藏
页码:E172 / E178
页数:7
相关论文
共 50 条
  • [41] Osteopontin deficiency protects mice from cholesterol gallstone formation by reducing expression of intestinal NPC1L1
    Lin, Jing
    Shao, Wei-Qing
    Chen, Qing-Zhi
    Zhu, Wen-Wei
    Lu, Lu
    Jia, Hu-Liang
    Chen, Jin-Hong
    MOLECULAR MEDICINE REPORTS, 2017, 16 (02) : 1785 - 1792
  • [42] SREBP2 mediates the modulation of intestinal NPC1L1 expression by curcumin
    Kumar, Pradeep
    Malhotra, Pooja
    Ma, Ke
    Singla, Amika
    Hedroug, Omar
    Saksena, Seema
    Dudeja, Pradeep K.
    Gill, Ravinder K.
    Alrefai, Waddah A.
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2011, 301 (01): : G148 - G155
  • [43] Identification of a Novel NPC1L1 Inhibitor from Danshen and Its Role in Nonalcoholic Fatty Liver Disease
    Xia, Donghai
    Jiang, Xuan
    Xie, Xiaomin
    Zhou, Han
    Yu, Dongping
    Jin, Gaowa
    Ye, Xianlong
    Zhu, Shenglong
    Guo, Zhimou
    Liang, Xinmiao
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (06)
  • [44] Lactobacillus mediates the expression of NPC1L1, CYP7A1, and ABCG5 genes to regulate cholesterol
    Cao, Kaihui
    Zhang, Kaiping
    Ma, Muran
    Ma, Junjie
    Tian, Jianjun
    Jin, Ye
    FOOD SCIENCE & NUTRITION, 2021, 9 (12): : 6882 - 6891
  • [45] Modulation of lipid metabolism with the overexpression of NPC1L1 in mouse liver
    Kurano, Makoto
    Hara, Masumi
    Tsuneyama, Koichi
    Okamoto, Koji
    Iso-O, Naoyuki
    Matsushima, Teruhiko
    Koike, Kazuhiko
    Tsukamoto, Kazuhisa
    JOURNAL OF LIPID RESEARCH, 2012, 53 (11) : 2275 - 2285
  • [46] Niemann-Pick C1 Like 1 (NPC1L1) an intestinal sterol transporter
    Davis, Harry R., Jr.
    Altmann, Scott W.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2009, 1791 (07): : 679 - 683
  • [47] Hepatic NPC1L1 overexpression attenuates alcoholic autophagy in mice
    Wang, Youlin
    Yang, Pan
    Zhang, Bo
    Ding, Yao
    Lei, Shun
    Hou, Yuning
    Guan, Xiaoqing
    Li, Qingwang
    MOLECULAR MEDICINE REPORTS, 2019, 20 (04) : 3224 - 3232
  • [48] Increased NPC1L1 and ACAT2 expression in the jejunal mucosa from Chinese gallstone patients
    Jiang, Zhao-Yan
    Jiang, Chong-Yi
    Wang, Lei
    Wang, Jian-Cheng
    Zhang, Sheng-Dao
    Einarsson, Curt
    Eriksson, Mats
    Han, Tian-Quan
    Parini, Paolo
    Eggertsen, Gosta
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2009, 379 (01) : 49 - 54
  • [49] Curcumin inhibits cholesterol uptake in Caco-2 cells by down-regulation of NPC1L1 expression
    Dan Feng
    Lena Ohlsson
    Rui-Dong Duan
    Lipids in Health and Disease, 9
  • [50] NPC1L1 is a key regulator of intestinal vitamin K absorption and a modulator of warfarin therapy
    Takada, Tappei
    Yamanashi, Yoshihide
    Konishi, Kentaro
    Yamamoto, Takehito
    Toyoda, Yu
    Masuo, Yusuke
    Yamamoto, Hideaki
    Suzuki, Hiroshi
    SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (275)